Please make plans to join the Behavioral Health Council webinar on June 3 at 11 a.m. to hear about the 2025 Notice of Funding Opportunity from the Georgia Opioid Crisis Abatement Trust. In 2021, a nationwide settlement was reached to resolve all opioids litigation brought by states and local political subdivisions against the three largest pharmaceutical distributors, McKesson, Cardinal Health, and AmerisourceBergen (“Distributors”) and against manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson (collectively, “J&J”). Georgia is anticipated to receive $638 million with approximately $30 million to be distributed in 2025.We have invited the Georgia Opioid Crisis Abatement Trust to present on their current funding opportunity which is open until June 18.Funding Information2025 Notice of Funding OpportunityResources and GAP AnalysisCreate an organization profileVisit the GHA Learning Academy for additional details and to register.
Please make plans to join the Behavioral Health Council webinar on June 3 at 11 a.m. to hear about the 2025 Notice of Funding Opportunity from the Georgia Opioid Crisis Abatement Trust. In 2021, a nationwide settlement was reached to resolve all opioids litigation brought by states and local political subdivisions against the three largest pharmaceutical distributors, McKesson, Cardinal Health, and AmerisourceBergen (“Distributors”) and against manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson (collectively, “J&J”). Georgia is anticipated to receive $638 million with approximately $30 million to be distributed in 2025.
We have invited the Georgia Opioid Crisis Abatement Trust to present on their current funding opportunity which is open until June 18.
Funding Information
2025 Notice of Funding OpportunityResources and GAP AnalysisCreate an organization profile
Visit the GHA Learning Academy for additional details and to register.